PubMed

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Sweetenham JW, Goldman B, Leblanc ML, Cook JR, Tubbs RR, Press OW, Maloney DG, Fisher RI, Rimsza LM, Braziel RM, Hsi ED.

Ann Oncol. 2009 Oct 29. [Epub ahead of print]PMID: 19875761 [PubMed - as supplied by publisher]Related articles

Outcomes of patients with burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.

Kelly JL, Toothaker SR, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead G, Thomas D, Van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW.

Clin Lymphoma Myeloma. 2009 Aug;9(4):307-10.PMID: 19717381 [PubMed - in process]Related articles

Involved Field Radiation after Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era.

Biswas T, Dhakal S, Chen R, Hyrien O, Bernstein S, Friedberg JW, Fisher RI, Liesveld J, Phillips G, Constine LS.

Int J Radiat Oncol Biol Phys. 2009 Jul 31. [Epub ahead of print]PMID: 19647953 [PubMed - as supplied by publisher]Related articles

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

Friedberg JW, Kelly JL, Neuberg D, Peterson DR, Kutok JL, Salloum R, Brenn T, Fisher DC, Ronan E, Dalton V, Rich L, Marquis D, Sims P, Rothberg PG, Liesveld J, Fisher RI, Coffman R, Mosmann T, Freedman AS.

Br J Haematol. 2009 Aug;146(3):282-91. Epub 2009 Jun 10.PMID: 19519691 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.

Stopeck AT, Unger JM, Rimsza LM, Bellamy WT, Iannone M, Persky DO, Leblanc M, Fisher RI, Miller TP.

Leuk Lymphoma. 2009 May;50(5):728-35.PMID: 19373598 [PubMed - indexed for MEDLINE]Related articles

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.

Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, Joyce R, Takvorian RW, Fisher DC, Fisher RI, Liesveld J, Marquis D, Neuberg D, Freedman AS.

Br J Haematol. 2009 Jun;145(6):741-8. Epub 2009 Mar 30.PMID: 19344412 [PubMed - indexed for MEDLINE]Related articles

Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress.

Dasmahapatra G, Lembersky D, Rahmani M, Kramer L, Friedberg J, Fisher RI, Dent P, Grant S.

Cancer Biol Ther. 2009 May;8(9):808-19. Epub 2009 May 8.PMID: 19270531 [PubMed - in process]Related articles

Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.

Hilchey SP, Hyrien O, Mosmann TR, Livingstone AM, Friedberg JW, Young F, Fisher RI, Kelleher RJ Jr, Bankert RB, Bernstein SH.

Blood. 2009 Apr 16;113(16):3809-12. Epub 2009 Feb 4.PMID: 19196657 [PubMed - indexed for MEDLINE]Related articles

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.

Goy A, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Nasta S, O'Connor OA, Shi H, Boral AL, Fisher RI.

Ann Oncol. 2009 Mar;20(3):520-5. Epub 2008 Dec 12.PMID: 19074748 [PubMed - indexed for MEDLINE]Related articles

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.

Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI.

J Clin Oncol. 2009 Jan 1;27(1):114-9. Epub 2008 Dec 1.PMID: 19047289 [PubMed - indexed for MEDLINE]Related articles

Stromal gene signatures in large-B-cell lymphomas.

Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

N Engl J Med. 2008 Nov 27;359(22):2313-23.PMID: 19038878 [PubMed - indexed for MEDLINE]Related articlesFree article

Diffuse large B-cell lymphoma.

Friedberg JW, Fisher RI.

Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix. Review.PMID: 18954744 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5. Epub 2008 Sep 2.PMID: 18765795 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

Swinnen LJ, LeBlanc M, Grogan TM, Gordon LI, Stiff PJ, Miller AM, Kasamon Y, Miller TP, Fisher RI.

Transplantation. 2008 Jul 27;86(2):215-22.PMID: 18645482 [PubMed - indexed for MEDLINE]Related articles

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.

Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW.

Ann Oncol. 2008 Oct;19(10):1759-64. Epub 2008 May 25.PMID: 18504251 [PubMed - indexed for MEDLINE]Related articlesFree article

Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma.

Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, Friedberg JW.

Cancer Invest. 2008 May;26(4):431-3.PMID: 18443965 [PubMed - indexed for MEDLINE]Related articles

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

Persky DO, Unger JM, Spier CM, Stea B, LeBlanc M, McCarty MJ, Rimsza LM, Fisher RI, Miller TP; Southwest Oncology Group.

J Clin Oncol. 2008 May 10;26(14):2258-63. Epub 2008 Apr 14.PMID: 18413640 [PubMed - indexed for MEDLINE]Related articles

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.

Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM.

Science. 2008 Mar 21;319(5870):1676-9. Epub 2008 Mar 6.PMID: 18323416 [PubMed - indexed for MEDLINE]Related articlesFree article

Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).

Thompson JA, Fisher RI, Leblanc M, Forman SJ, Press OW, Unger JM, Nademanee AP, Stiff PJ, Petersdorf SH, Fefer A.

Blood. 2008 Apr 15;111(8):4048-54. Epub 2008 Feb 6.PMID: 18256325 [PubMed - indexed for MEDLINE]Related articlesFree article

Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma.

Schaefer-Cutillo J, Friedberg JW, Fisher RI.

Oncology (Williston Park). 2007 Feb;21(2):203-12; discussion 214, 217, 221. Review.PMID: 17396483 [PubMed - indexed for MEDLINE]Related articles

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.

Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM.

J Exp Med. 2007 Mar 19;204(3):633-43. Epub 2007 Mar 12.PMID: 17353367 [PubMed - indexed for MEDLINE]Related articlesFree article

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.

Blood. 2007 Jun 1;109(11):4599-606. Epub 2007 Feb 13.PMID: 17299095 [PubMed - indexed for MEDLINE]Related articlesFree article

Revised response criteria for malignant lymphoma.

Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma.

J Clin Oncol. 2007 Feb 10;25(5):579-86. Epub 2007 Jan 22.PMID: 17242396 [PubMed - indexed for MEDLINE]Related articles

Treatment of diffuse large B-cell lymphomas.

Fisher RI.

Semin Hematol. 2006 Oct;43(4):205-6. No abstract available. PMID: 17027653 [PubMed - indexed for MEDLINE]Related articles

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I.

Clin Immunol. 2007 Feb;122(2):139-45. Epub 2006 Sep 27.PMID: 17008130 [PubMed - indexed for MEDLINE]Related articles

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Fisher RI, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Stadtmauer EA, O'Connor OA, Shi H, Boral AL, Goy A.

J Clin Oncol. 2006 Oct 20;24(30):4867-74. Epub 2006 Sep 25.PMID: 17001068 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

Press OW, Unger JM, Braziel RM, Maloney DG, Miller TP, Leblanc M, Fisher RI; Southwest Oncology Group.

J Clin Oncol. 2006 Sep 1;24(25):4143-9. Epub 2006 Aug 8.PMID: 16896003 [PubMed - indexed for MEDLINE]Related articles

The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.

Fisher SG, Fisher RI.

Curr Opin Oncol. 2006 Sep;18(5):417-24. Review.PMID: 16894287 [PubMed - indexed for MEDLINE]Related articles

Venous thromboembolism in patients with diffuse large B-cell lymphoma.

Komrokji RS, Uppal NP, Khorana AA, Lyman GH, Kaplan KL, Fisher RI, Francis CW.

Leuk Lymphoma. 2006 Jun;47(6):1029-33.PMID: 16840193 [PubMed - indexed for MEDLINE]Related articles

Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas.

Fisher RI, Coiffier B, Vose JM.

Clin Adv Hematol Oncol. 2006 Apr;4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10.PMID: 16775878 [PubMed - indexed for MEDLINE]Related articles

Molecular diagnosis of Burkitt's lymphoma.

Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

N Engl J Med. 2006 Jun 8;354(23):2431-42.PMID: 16760443 [PubMed - indexed for MEDLINE]Related articlesFree article

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ.

J Clin Oncol. 2006 Jul 1;24(19):3121-7. Epub 2006 Jun 5.PMID: 16754935 [PubMed - indexed for MEDLINE]Related articles

Diffuse large B-cell NHL.

Friedberg JW, Fisher RI.

Cancer Treat Res. 2006;131:121-40. Review. No abstract available. PMID: 16704168 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

Winter JN, Weller EA, Horning SJ, Krajewska M, Variakojis D, Habermann TM, Fisher RI, Kurtin PJ, Macon WR, Chhanabhai M, Felgar RE, Hsi ED, Medeiros LJ, Weick JK, Reed JC, Gascoyne RD.

Blood. 2006 Jun 1;107(11):4207-13. Epub 2006 Jan 31. Erratum in: Blood. 2007 Mar 15;109(6):2292. PMID: 16449523 [PubMed - indexed for MEDLINE]Related articlesFree article

Thromboembolism in hospitalized neutropenic cancer patients.

Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.

J Clin Oncol. 2006 Jan 20;24(3):484-90.PMID: 16421425 [PubMed - indexed for MEDLINE]Related articles

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, Jaffe ES, Gascoyne RD, Chan WC, Weisenburger DD, Greiner T, Braziel RM, Miller TP.

Blood. 2006 Feb 1;107(3):1101-7. Epub 2005 Oct 20.PMID: 16239429 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Vose JM, Link BK, Grossbard ML, Czuczman M, Grillo-Lopez A, Fisher RI.

Leuk Lymphoma. 2005 Nov;46(11):1569-73.PMID: 16236611 [PubMed - indexed for MEDLINE]Related articles

New treatment options have changed the survival of patients with follicular lymphoma.

Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP.

J Clin Oncol. 2005 Nov 20;23(33):8447-52. Epub 2005 Oct 17.PMID: 16230674 [PubMed - indexed for MEDLINE]Related articles

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.

Fisher RI, Kaminski MS, Wahl RL, Knox SJ, Zelenetz AD, Vose JM, Leonard JP, Kroll S, Goldsmith SJ, Coleman M.

J Clin Oncol. 2005 Oct 20;23(30):7565-73. Epub 2005 Sep 26.PMID: 16186600 [PubMed - indexed for MEDLINE]Related articles

Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL.

Fisher RI.

Clin Adv Hematol Oncol. 2005 Jul;3(7):544-6. No abstract available. PMID: 16167036 [PubMed - indexed for MEDLINE]Related articles

Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphoma.

Fisher RI.

Clin Adv Hematol Oncol. 2005 Jul;3(7):544-6. Review. No abstract available. PMID: 16167035 [PubMed - indexed for MEDLINE]Related articles

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A; Lymphoma/Leukemia Molecular Profiling Project.

Blood. 2005 Nov 1;106(9):3183-90. Epub 2005 Jul 26.PMID: 16046532 [PubMed - indexed for MEDLINE]Related articlesFree article

Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.

Song L, Zlobin A, Ghoshal P, Zhang Q, Houde C, Weijzen S, Jiang Q, Nacheva E, Yagan D, Davis E, Galiegue-Zouitina S, Catovsky D, Grogan T, Fisher RI, Miele L, Coignet LJ.

Cancer Res. 2005 Jun 1;65(11):4554-61.PMID: 15930272 [PubMed - indexed for MEDLINE]Related articlesFree article

Meta-analysis to evaluate the role of interferon in follicular lymphoma.

Rohatiner AZ, Gregory WM, Peterson B, Borden E, Solal-Celigny P, Hagenbeek A, Fisher RI, Unterhalt M, Arranz R, Chisesi T, Aviles A, Lister TA.

J Clin Oncol. 2005 Apr 1;23(10):2215-23. Epub 2005 Jan 31.PMID: 15684317 [PubMed - indexed for MEDLINE]Related articles

Mantle cell lymphoma: at last, some hope for successful innovative treatment strategies.

Fisher RI.

J Clin Oncol. 2005 Feb 1;23(4):657-8. Epub 2004 Dec 21. No abstract available. PMID: 15613690 [PubMed - indexed for MEDLINE]Related articles

Diffuse aggressive lymphoma.

Fisher RI, Miller TP, O'Connor OA.

Hematology Am Soc Hematol Educ Program. 2004:221-36. Review.PMID: 15561685 [PubMed - indexed for MEDLINE]Related articlesFree article

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, Montserrat E, Wilson WH, Jaffe ES, Simon R, Yang L, Powell J, Zhao H, Goldschmidt N, Chiorazzi M, Staudt LM.

N Engl J Med. 2004 Nov 18;351(21):2159-69.PMID: 15548776 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI.

J Clin Oncol. 2004 Nov 1;22(21):4302-11. Epub 2004 Sep 20.PMID: 15381684 [PubMed - indexed for MEDLINE]Related articles

The epidemiology of non-Hodgkin's lymphoma.

Fisher SG, Fisher RI.

Oncogene. 2004 Aug 23;23(38):6524-34. Review.PMID: 15322522 [PubMed - indexed for MEDLINE]Related articles

Follicular lymphoma international prognostic index.

Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haïoun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E.

Blood. 2004 Sep 1;104(5):1258-65. Epub 2004 May 4.PMID: 15126323 [PubMed - indexed for MEDLINE]Related articlesFree article